363 related articles for article (PubMed ID: 26808063)
1. UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance.
Chen YX; Zhang XJ; Huang J; Zhou SJ; Liu F; Jiang LL; Chen M; Wan JB; Yang DZ
J Pharm Biomed Anal; 2016 Mar; 121():141-150. PubMed ID: 26808063
[TBL] [Abstract][Full Text] [Related]
2. Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach.
Dong F; Deng D; Chen H; Cheng W; Li Q; Luo R; Ding S
Anal Bioanal Chem; 2015 Jun; 407(16):4683-95. PubMed ID: 25860656
[TBL] [Abstract][Full Text] [Related]
3. Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC-MS and chemometrics approach.
Zhang XJ; Huang LL; Su H; Chen YX; Huang J; He C; Li P; Yang DZ; Wan JB
J Pharm Biomed Anal; 2014 Jul; 95():85-92. PubMed ID: 24637052
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes.
Zhou W; Hong Y; Yin A; Liu S; Chen M; Lv X; Nie X; Tan N; Zhang Z
J Pharm Biomed Anal; 2020 Jun; 185():113262. PubMed ID: 32222648
[TBL] [Abstract][Full Text] [Related]
5. Lipidomics biomarkers in women with polycystic ovary syndrome (PCOS) using ultra-high performance liquid chromatography-quadrupole time of flight electrospray in a positive ionization mode mass spectrometry.
Vonica CL; Ilie IR; Socaciu C; Moraru C; Georgescu B; Farcaş A; Roman G; Mureşan AA; Georgescu CE
Scand J Clin Lab Invest; 2019 Oct; 79(6):437-442. PubMed ID: 31462125
[TBL] [Abstract][Full Text] [Related]
6. Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome.
Zhang Z; Hong Y; Chen M; Tan N; Liu S; Nie X; Zhou W
Metabolomics; 2020 Jan; 16(2):20. PubMed ID: 31980950
[TBL] [Abstract][Full Text] [Related]
7. Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry.
Zhao X; Xu F; Qi B; Hao S; Li Y; Li Y; Zou L; Lu C; Xu G; Hou L
J Proteome Res; 2014 Feb; 13(2):1101-11. PubMed ID: 24428203
[TBL] [Abstract][Full Text] [Related]
8. Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics technique.
Buszewska-Forajta M; Rachoń D; Stefaniak A; Wawrzyniak R; Konieczna A; Kowalewska A; Markuszewski MJ
J Steroid Biochem Mol Biol; 2019 Feb; 186():176-184. PubMed ID: 30670174
[TBL] [Abstract][Full Text] [Related]
9. Serum metabolomics study of Traditional Chinese medicine formula intervention to polycystic ovary syndrome.
Lu C; Zhao X; Li Y; Li Y; Yuan C; Xu F; Meng X; Hou L; Xu G
J Pharm Biomed Anal; 2016 Feb; 120():127-33. PubMed ID: 26730509
[TBL] [Abstract][Full Text] [Related]
10. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
[TBL] [Abstract][Full Text] [Related]
11. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
12. Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry.
Jia C; Xu H; Xu Y; Xu Y; Shi Q
Mol Reprod Dev; 2019 Mar; 86(3):292-297. PubMed ID: 30624822
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.
Zhao Y; Fu L; Li R; Wang LN; Yang Y; Liu NN; Zhang CM; Wang Y; Liu P; Tu BB; Zhang X; Qiao J
BMC Med; 2012 Nov; 10():153. PubMed ID: 23198915
[TBL] [Abstract][Full Text] [Related]
14. How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics.
Zhao X; Feng X; Zhao X; Jiang Y; Li X; Niu J; Meng X; Wu J; Xu G; Hou L; Wang Y
Front Endocrinol (Lausanne); 2021; 12():659268. PubMed ID: 34149613
[TBL] [Abstract][Full Text] [Related]
15. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
[TBL] [Abstract][Full Text] [Related]
16. Identification of Potential Biomarkers for Urine Metabolomics of Polycystic Ovary Syndrome Based on Gas Chromatography-Mass Spectrometry.
Zou Y; Zhu FF; Fang CY; Xiong XY; Li HY
Chin Med J (Engl); 2018 Apr; 131(8):945-949. PubMed ID: 29664055
[TBL] [Abstract][Full Text] [Related]
17. Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome.
Cree-Green M; Carreau AM; Rahat H; Garcia-Reyes Y; Bergman BC; Pyle L; Nadeau KJ
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E707-E718. PubMed ID: 30753112
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry.
Sun Z; Chang HM; Wang A; Song J; Zhang X; Guo J; Leung PCK; Lian F
Reprod Biol Endocrinol; 2019 Jun; 17(1):45. PubMed ID: 31186025
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics reveals positive acceleration(+Gz)-induced metabolic perturbations and the protective effect of Ginkgo biloba extract in a rat model based on ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Yang Z; Zhao A; Li Z; Ge H; Li T; Zhang F; Zhan H; Wang J
J Pharm Biomed Anal; 2016 Jun; 125():77-84. PubMed ID: 27010354
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome.
Cankaya S; Demir B; Aksakal SE; Dilbaz B; Demirtas C; Goktolga U
Fertil Steril; 2014 Sep; 102(3):826-30. PubMed ID: 24973036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
